SAT525 Long-Term Outcomes in Stage I Thyroid Cancer Without Radioiodine Remnant Ablation

Disclosure: F. Mubeen: None. M. Zahid: None. T.D. Cubb: None. J. Shakil: None. J. Xu: None. R.J. Robbins: None. Introduction: Although differentiated thyroid cancer (DTC) has low mortality, the risk of recurrence after thyroidectomy is not negligible. In the past radioiodine was routinely given to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mubeen, Faiza, Zahid, Maleeha, Cubb, Trisha D, Shakil, Jawairia, Xu, Jiaqiong, Robbins, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553410/
http://dx.doi.org/10.1210/jendso/bvad114.1997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553410/
http://dx.doi.org/10.1210/jendso/bvad114.1997

Ejemplares similares